Author: Brian Dahl

Brian Dahl is the senior director and practice lead for corporate compliance and ethics at ProPharma Group.

Corporate Compliance Programs: The Importance of Being Effective

Now more than ever, pharmaceutical companies must not only have an effective Corporate Compliance Program in place, but senior management and boards of directors at these companies must ensure that their Corporate Compliance departments evaluate the effectiveness of those Programs. The federal government has sent numerous signals of its intent to hold the highest levels … Continue reading “Corporate Compliance Programs: The Importance of Being Effective”